Literature DB >> 27115266

Does This Patient Have Infectious Mononucleosis?: The Rational Clinical Examination Systematic Review.

Mark H Ebell1, Marlene Call2, JoAnna Shinholser1, Jack Gardner1.   

Abstract

IMPORTANCE: Early, accurate diagnosis of infectious mononucleosis can help clinicians target treatment, avoid antibiotics, and provide an accurate prognosis.
OBJECTIVE: To systematically review the literature regarding the value of the clinical examination and white blood cell count for the diagnosis of mononucleosis. DATA SOURCES: The databases of PubMed (from 1966-2016) and EMBASE (from 1947-2015) were searched and a total of 670 articles and abstracts were reviewed for eligibility. STUDY SELECTION: Eleven studies were included that reported data sufficient to calculate sensitivity, specificity, or both for clinical examination findings and white blood cell count parameters compared with a valid reference standard. DATA EXTRACTION AND SYNTHESIS: Data were abstracted from each article by at least 2 reviewers, with discrepancies reconciled by consensus. Clinical findings evaluated in only 1 study are reported with sensitivity, specificity, likelihood ratio (LR), and 95% confidence interval, which were calculated from the available data. Findings evaluated in only 2 studies were summarized with their range, findings evaluated in 3 studies were summarized with a univariate random-effects summary, and findings evaluated in 4 or more studies were summarized with a bivariate random-effects meta-analysis. MAIN OUTCOMES AND MEASURES: Sensitivity, specificity, and LRs for the diagnosis of mononucleosis.
RESULTS: Mononucleosis is most commonly present among patients aged 5 to 25 years (especially those aged 16-20 years, among whom approximately 1 in 13 patients presenting with sore throat has mononucleosis). The likelihood of mononucleosis is reduced with the absence of any lymphadenopathy (summary sensitivity, 0.91; positive LR range, 0.23-0.44), whereas the likelihood increases with the presence of posterior cervical adenopathy (summary specificity, 0.87; positive LR, 3.1 [95% CI, 1.6-5.9]), inguinal or axillary adenopathy (specificity range, 0.82-0.91; positive LR range, 3.0-3.1), palatine petechiae (specificity, 0.95; positive LR, 5.3 [95% CI, 2.1-13]), and splenomegaly (specificity range, 0.71-0.99; positive LR range, 1.9-6.6). Symptoms are of limited value for the diagnosis of mononucleosis; sore throat and fatigue are sensitive (range, 0.81-0.83) but nonspecific. The presence of atypical lymphocytosis significantly increases the likelihood of mononucleosis (summary LR, 11.4 [95% CI, 2.7-35] for atypical lymphocytes ≥10%, 26 [95% CI, 9.6-68] for those with 20%, and 50 [95% CI, 38-64] for those with 40%). The combination of a patient having greater than 50% lymphocytes and greater than 10% atypical lymphocytes also is useful (specificity, 0.99; positive LR, 54 [95% CI, 8.4-189]). CONCLUSIONS AND RELEVANCE: In adolescent and adult patients presenting with sore throat, the presence of posterior cervical, inguinal or axillary adenopathy, palatine petechiae, splenomegaly, or atypical lymphocytosis is associated with an increased likelihood of mononucleosis.

Entities:  

Mesh:

Year:  2016        PMID: 27115266     DOI: 10.1001/jama.2016.2111

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  12 in total

1.  [Fulminant EBV meningoencephalitis : Good clinical outcome in a young, immunocompetent female].

Authors:  F Derler; S Seidel; D Bengel
Journal:  Nervenarzt       Date:  2017-10       Impact factor: 1.214

2.  Interleukin-35 has a Protective Role in Infectious Mononucleosis-Induced Liver Inflammation Probably by Inhibiting CD8+ T Cell Function.

Authors:  Ying Gao; Lan Li; Xingxing Hu; Weihua Zhang; Yu Li
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2022-10-11       Impact factor: 3.831

3.  Pancreatitis Combined with Epstein-Barr Virus-induced Infectious Mononucleosis.

Authors:  Zhen Zhu; Shao-Jun Yin; Zhi-Bin Kong; Hong Li; Liu-Ping Hu; Shen Zuo; Yi Liu; Shuang Song; Hua Liu; Amber Lee
Journal:  Chin Med J (Engl)       Date:  2017-08-20       Impact factor: 2.628

4.  Understanding the predictive value of continuous markers for censored survival data using a likelihood ratio approach.

Authors:  Andrew M Smith; John P Christodouleas; Wei-Ting Hwang
Journal:  BMC Med Res Methodol       Date:  2019-05-22       Impact factor: 4.615

5.  Clinical differentiation of infectious mononucleosis that is caused by Epstein-Barr virus or cytomegalovirus: A single-center case-control study in Japan.

Authors:  Takamasa Ishii; Yosuke Sasaki; Tadashi Maeda; Fumiya Komatsu; Takeshi Suzuki; Yoshihisa Urita
Journal:  J Infect Chemother       Date:  2019-02-15       Impact factor: 2.211

6.  Clinical Characteristics and the Risk Factors of Hepatic Injury in 221 Children With Infectious Mononucleosis.

Authors:  Chao Zhang; Shu Cui; Guoshun Mao; Guitao Li
Journal:  Front Pediatr       Date:  2022-01-12       Impact factor: 3.418

7.  An Atypical Presentation of Epstein-Barr Virus Associated Infectious Mononucleosis Mistaken for Pyelonephritis.

Authors:  Cassandra Kien; Kavitha Ganta
Journal:  Cureus       Date:  2020-04-07

8.  Fine needle cytology features of an atypical presentation of infectious mononucleosis.

Authors:  Roberto Gerber-Mora; Verónica Peña Y Lillo; Ricardo Moreno-Silva; Wilfredo González-Arriagada
Journal:  J Oral Maxillofac Pathol       Date:  2020-02-28

9.  The authors respond to comments from Vermaak and Stahlbrand.

Authors:  Hiroaki Nakagawa; Yasushi Miyata
Journal:  CMAJ       Date:  2021-07-26       Impact factor: 8.262

10.  Comparison of clinical characteristics of a patient with Epstein-Barr virus-associated seizure and patients with COVID-19-associated seizure.

Authors:  Larry Nichols; Merritt Thompson; Gretchen L Bentz
Journal:  J Med Virol       Date:  2021-07-20       Impact factor: 20.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.